Session Chair Profile

Pioneering precision medicine clinical trials & studies in the US and around the world, and the use of liquid biopsy to predict immunotherapy

M.D., FACP, Center Associate Director, Professor, Medical College of Wisconsin

Dr. Kurzrock is a board-certified medical oncologist and a renowned expert in precision medicine. She is known for developing one of the largest and best known Phase I clinical trial programs in the United States while at MD Anderson Cancer Center in Texas. Dr. Kurzrock established the UCSD’s Center for Personalized Cancer Therapy at the Moores Cancer Center. The center focuses on genomically-driven therapy as well as precision immunotherapy, especially in rare cancers. Dr. Kurzrock is a global leader in personalized medicine, bringing the first transcriptomic study to the clinic in an international setting spanning five countries (WINTHER), as well as the first study of individually customized combination therapy (IPREDICT). Dr. Kurzrock received her MD from the University of Toronto, Canada. She has over 800 PubMed publications, an H-index of 122, has been named to the lists of most highly cited scientists in the world and the 25 world leaders in precision medicine, and she has a uniquely strong record of competitive funding with more than 100 million dollars in lifetime funding.

 Session Abstract – PMWC 2023 Silicon Valley

Track 4, January 26

Track Chair: Cindy Perettie, Roche

  • PMWC 2023 Award Ceremony
    - Luis Alberto Diaz Jr., MSK
    - Razelle Kurzrock: Medical College of Wisconsin
  • Non-invasive Liquid Biopsy Techniques
    Chair: Razelle Kurzrock, Medical College of Wisconsin
    - Apostolia Tsimberidou, MD Anderson
    - Mandana Kamgar, MD Medical College of Wisconsin
    - Mina Nikanjam, UCSD
    - Ash alizadeh, Stanford University
  • Liquid Biopsy Challenges and Limitations
    Chair: Luis Alberto Diaz Jr., MSK
    - Maximilian Diehn, Stanford
  • Liquid Biopsy in Clinical Trials: Learnings and COVID Experience
  • Liquid Biopsy for Early Cancer Detection
    Chair: Priti Hegde, Foundation Medicine
  • Liquid Biopsy for Minimal Residual Disease (MRD)
    Chair: Minetta Liu, Natera